Medy-Tox Inc. (KOSDAQ:A086900) announces a share repurchases program. Under the program, the company will repurchase up to 41,771 shares. The purpose of the buyback is to stabilize stock price and increase shareholder value.

The plan will be valid up to November 15, 2022. As of August 16, 2022, the company had 542,431 shares in treasury within scope available for dividend and had 42,413 common stock and 14 other stock in treasury through other repurchase.